These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2543771)

  • 41. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
    La Monica N; Meriam C; Racaniello VR
    J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China.
    Tao Z; Wang H; Xu A; Zhang Y; Song L; Zhu S; Li Y; Yan D; Liu G; Yoshida H; Liu Y; Feng L; Chosa T; Xu W
    Virus Res; 2010 Jun; 150(1-2):56-60. PubMed ID: 20206214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
    Mosser AG; Sgro JY; Rueckert RR
    J Virol; 1994 Dec; 68(12):8193-201. PubMed ID: 7966611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions.
    Duncan G; Pelletier I; Colbère-Garapin F
    Virology; 1998 Feb; 241(1):14-29. PubMed ID: 9454713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrimidine-rich region mutations compensate for a stem-loop V lesion in the 5' noncoding region of poliovirus genomic RNA.
    Stewart SR; Semler BL
    Virology; 1999 Nov; 264(2):385-97. PubMed ID: 10562500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
    Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
    Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.
    McGoldrick A; Macadam AJ; Dunn G; Rowe A; Burlison J; Minor PD; Meredith J; Evans DJ; Almond JW
    J Virol; 1995 Dec; 69(12):7601-5. PubMed ID: 7494267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategy for construction of live picornavirus vaccines.
    Nomoto A; Iizuka N; Kohara M; Arita M
    Vaccine; 1988 Apr; 6(2):134-7. PubMed ID: 2838985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications.
    Muzychenko AR; Lipskaya GYu ; Maslova SV; Svitkin YV; Pilipenko EV; Nottay BK; Kew OM; Agol VI
    Virus Res; 1991 Oct; 21(2):111-22. PubMed ID: 1661980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus.
    Weeks-Levy C; Tatem JM; DiMichele SJ; Waterfield W; Georgiu AF; Mento SJ
    Virology; 1991 Dec; 185(2):934-7. PubMed ID: 1660210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.
    Kirkegaard K
    J Virol; 1990 Jan; 64(1):195-206. PubMed ID: 2152812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The 5' noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity.
    Macadam AJ; Pollard SR; Ferguson G; Dunn G; Skuce R; Almond JW; Minor PD
    Virology; 1991 Apr; 181(2):451-8. PubMed ID: 1707566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins.
    Emini EA; Leibowitz J; Diamond DC; Bonin J; Wimmer E
    Virology; 1984 Aug; 137(1):74-85. PubMed ID: 6089422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence.
    Agol VI; Grachev VP; Drozdov SG; Kolesnikova MS; Kozlov VG; Ralph NM; Romanova LI; Tolskaya EA; Tyufanov AV; Viktorova EG
    Virology; 1984 Jul; 136(1):41-55. PubMed ID: 6330995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.
    Stanway G; Hughes PJ; Mountford RC; Reeve P; Minor PD; Schild GC; Almond JW
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1539-43. PubMed ID: 6324200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5' noncoding region.
    Andino R; Rieckhof GE; Trono D; Baltimore D
    J Virol; 1990 Feb; 64(2):607-12. PubMed ID: 2153227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intertypic recombination in poliovirus: genetic and biochemical studies.
    Tolskaya EA; Romanova LA; Kolesnikova MS; Agol VI
    Virology; 1983 Jan; 124(1):121-32. PubMed ID: 6297149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural variants of the Sabin type 1 vaccine strain of poliovirus and correlation with a poliovirus neutralization site.
    Jameson BA; Bonin J; Wimmer E; Kew OM
    Virology; 1985 May; 143(1):337-41. PubMed ID: 2998009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.